Literature DB >> 500329

Rhabdoviridae. Report of the Rhabdovirus Study Group, International Committee on Taxonomy of Viruses.

F Brown, D H Bishop, J Crick, R I Francki, J J Holland, R Hull, K Johnson, G Martelli, F A Murphy, J F Obijeski, D Peters, C R Pringle, M E Reichmann, L G Schneider, R E Shope, D I Simpson, D F Summers, R R Wagner.   

Abstract

The family Rhabdoviridae comprises approximately 75 viruses infecting vertebrates, invertebrates and plants. The main characteristics of the member viruses are: (i) the viruses infecting vertebrates and invertebrates are bullet-shaped and the viruses infecting plants are usually bacilliform; (ii) the viruses have particle lengths varying from 130 to 380 nm and widths varying from 60 to 95 nm; (iii) the viruses possess unit-membrane envelopes from which protrude spikes 5 to 10 nm long; (iv) the viruses have precisely coiled helical nuecleocapsids with a diameter of approx. 50 nm; (v) most of the viruses which have been studied contain 5 proteins; the prototype, vesicular stomatitis virus, contains proteins designated L (large), G (glycoprotein), N (nucleoprotein), NS (nonstructural) and M (matrix); N or NS is phosphorylated in most members which have been studied; (vi) the viruses contain single-stranded RNA which is transcribed into several messenger RNA species with sizes corresponding to the structural proteins; (vii) the nucleocapsid contains the RNA-dependent RNA polymerase and is infectious; and (viii) many of the viruses produce morphologically distinct defective-interfering (T) particles.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500329     DOI: 10.1159/000149062

Source DB:  PubMed          Journal:  Intervirology        ISSN: 0300-5526            Impact factor:   1.763


  10 in total

1.  Development of an immunoglobulin M (IgM) capture enzyme-linked immunosorbent assay for detection of equine and swine IgM antibodies to vesicular stomatitis virus.

Authors:  E M Zhou; J Riva; A Clavijo
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

Review 2.  The genetics of vesiculoviruses.

Authors:  C R Pringle
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Proposal for a uniform nomenclature for defective interfering viruses of vesicular stomatitis virus.

Authors:  M E Reichmann; D H Bishop; F Brown; J Crick; J J Holland; C Y Kang; R Lazzarini; S Moyer; J Perrault; L Prevec; C R Pringle; R R Wagner; J S Youngner; A S Huang
Journal:  J Virol       Date:  1980-06       Impact factor: 5.103

4.  The glycoproteins of seven vesiculoviruses are antigenically distinct. Brief report.

Authors:  C R Wilks; J A House
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

5.  Rabies mRNA translation in Xenopus laevis oocytes.

Authors:  W H Wunner; P J Curtis; T J Wiktor
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

6.  Susceptibility of various animals to the vesiculoviruses Isfahan and Chandipura.

Authors:  C R Wilks; J A House
Journal:  J Hyg (Lond)       Date:  1986-10

7.  Koolpinyah and Yata viruses: two newly recognised ephemeroviruses from tropical regions of Australia and Africa.

Authors:  Kim R Blasdell; Steven G Widen; Sinéad M Diviney; Cadhla Firth; Thomas G Wood; Hilda Guzman; Edward C Holmes; Robert B Tesh; Nikos Vasilakis; Peter J Walker
Journal:  Vet Microbiol       Date:  2014-10-14       Impact factor: 3.293

8.  Susceptibility of various animals to the vesiculovirus Piry.

Authors:  C R Wilks; J A House
Journal:  J Hyg (Lond)       Date:  1984-08

9.  Effects of halofuginone lactate on lymphocytes and MDBK cells infected with Theileria annulata and/or vesicular stomatitis virus (VSV): an in vitro study.

Authors:  H Mehlhorn; W Raether
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

10.  Recoding of the vesicular stomatitis virus L gene by computer-aided design provides a live, attenuated vaccine candidate.

Authors:  Bingyin Wang; Chen Yang; Gergely Tekes; Steffen Mueller; Aniko Paul; Sean P J Whelan; Eckard Wimmer
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.